Histopathologic Analysis of Explanted Transvaginal Polypropylene Mesh

Authors

  • Mathilde Rousseau Division of Regenerative Medicine, Centre de Recherche du CHU de Québec – Université Laval, and Department of Surgery, Faculty of Medicine, Université Laval, Quebec (QC), Canada
  • Chaojing Li Key Laboratory of Textile Science & Technology, Ministry of Education and College of Textiles, Donghua University, Shanghai, China
  • Kairui Wei Key Laboratory of Textile Science & Technology, Ministry of Education and College of Textiles, Donghua University, Shanghai, China
  • Yan Li Key Laboratory of Textile Science & Technology, Ministry of Education and College of Textiles, Donghua University, Shanghai, China
  • Eric Philippe Division of Regenerative Medicine, Centre de Recherche du CHU de Québec – Université Laval, and Department of Surgery, Faculty of Medicine, Université Laval, Quebec (QC), Canada
  • Yile Sun Division of Regenerative Medicine, Centre de Recherche du CHU de Québec – Université Laval, and Department of Surgery, Faculty of Medicine, Université Laval, Quebec (QC), Canada and Department of Shanghai Lung Cancer Center and the Shanghai Key Laboratory of Thoracic Tumor Biotherapy, Shanghai Chest Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
  • Shiwei Zhao Division of Regenerative Medicine, Centre de Recherche du CHU de Québec – Université Laval, and Department of Surgery, Faculty of Medicine, Université Laval, Quebec (QC), Canada and Department of General Surgery, Huadong Hospital, Fudan University, Shanghai, China
  • Yuling Wu Division of Regenerative Medicine, Centre de Recherche du CHU de Québec – Université Laval, and Department of Surgery, Faculty of Medicine, Université Laval, Quebec (QC), Canada and Department of Anesthesiology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China
  • Caroline Rhéaume Division of Reproduction, Maternal and Child Health, Centre de Recherche du CHU de Québec – Université Laval, and Department of Obstetrics, Gynecology and Reproduction, Faculty of Medicine, Université Laval, Quebec (QC), Canada
  • Lu Wang Key Laboratory of Textile Science & Technology, Ministry of Education and College of Textiles, Donghua University, Shanghai, China
  • Ze Zhang Division of Regenerative Medicine, Centre de Recherche du CHU de Québec – Université Laval, and Department of Surgery, Faculty of Medicine, Université Laval, Quebec (QC), Canada
  • Gaëtan Brochu Division of Regenerative Medicine, Centre de Recherche du CHU de Québec – Université Laval, and Department of Surgery, Faculty of Medicine, Université Laval, Quebec (QC), Canada
  • Geneviève Nadeau Division of Endocrinology and Nephrology, Centre de Recherche du CHU de Québec – Université Laval, and Department of Surgery, Faculty of Medicine, Université Laval, Quebec (QC), Canada
  • Robert Guidoin Division of Regenerative Medicine, Centre de Recherche du CHU de Québec – Université Laval, and Department of Surgery, Faculty of Medicine, Université Laval, Quebec (QC), Canada

DOI:

https://doi.org/10.14738/bjhr.1305.12208

Keywords:

Pelvic floor disorders, polypropylene mesh, adverse events, polypropylene degradation

Abstract

Background: Transvaginal polypropylene (PP) meshes used to treat pelvic floor disorders have raised safety concerns due to adverse events. There is still considerable uncertainty about the causes of these complications. Objective: To identify the histological patterns that contribute to adverse events associated with PP meshes in the surgical treatment of pelvic organ prolapse (POP) and stress urinary incontinence (SUI). Study design: Eight explants were collected from seven patients (POP: four; SUI: two; POP and SUI: one), explantation due to mesh exposure or recurrent prolapse. Macroscopic and histological analyses were performed using scanning electron microscopy, light microscopy, and transmission electron microscopy. Results: Two distinct tissue responses were identified. Explants retrieved within 25 months showed rigid encapsulation by dense, well-organized collagen bundles with regular banding. In contrast, meshes removed after 33 months displayed disrupted or absent encapsulation, bacterial colonization, and significant surface degradation. Oxidative stress led to fiber fragmentation and cracking, releasing micro-debris that intensified local inflammation. Biofilm development further compromised the fibrous capsule, resulting in mesh exposure and infection in long-term cases. Conclusion: PP meshes show progressive degradation and inadequate long-term tissue integration. While early encapsulation by fibrotic tissue occurs, it fails to prevent chronic inflammation. Over time, bacterial colonization and oxidative degradation compromise the implant, often requiring removal. These findings highlight the need for alternative materials, such as polyvinylidene fluoride (PVDF), and strategies to prevent biofilm formation. Bacteriophage therapy may offer a new approach to manage mesh-related infections. Further studies with larger sample sizes are needed to confirm these results.

References

Dmochowski RR, Blaivas JM, Gormley EA, et al. Update of AUA guideline on the surgical management of female stress urinary incontinence. J Urol. 2010; 183(5):1906–1914.

Stanford EJ, Cassidenti A, Moen MD. Traditional native tissue versus mesh-augmented pelvic organ prolapse repairs: Providing an accurate interpretation of current literature. Int Urogynecol J. 2012; 23:19-28. doi: 10.1007/s00192-011-1584-z.

Cervigni M, Natale F. The use of synthetics in the treatment of pelvic organ prolapse. Curr Opin Urol. 2001; 11:429-435.

Chapple CR, Cruz F, Deffieux X, et al. Consensus statement of the European Urology Association and European Urogynaecological Association on the use of implanted materials for treating pelvic organ prolapse and stress urinary incontinence. Eur Urol 2017;72(3):424–431.

Ellington DR, Richter HE. The role of vaginal mesh procedures in pelvic organ prolapse surgery in view of complication risk. Obstet Gynecol Int. 2013:356960.

Food and Drug Administration HHS, Department of Health and Human Services – Obstetrical and Gynecological devices: reclassification of surgical mesh for transvaginal pelvic organ prolapse repair. January 2016, vol. 81, n° 2.

Margulies RU, Lewicky-Gaupp C, Fenner DE, et al. Complications requiring reoperation following vaginal mesh kit procedures for prolapse. Am J Obstet Gynecol. 2008; 199:678.e1-4.

Mistrangelo E, Mancuso S, Nadalini C, et al. Rising use of synthetic mesh in transvaginal pelvic reconstructive surgery: A review of the risk of vaginal erosion. J Minim Invasive Gynecol. 2007; 14:564-569. doi: 10.1016/j.mig.2007.04.017.

FDA Public Health notification: Serious complications associated with transvaginal placement of surgical mesh in repair of pelvic organ prolapsed and stress urinary incontinence, October 2008. Scholar Publishing

FDA Executive Summary. Surgical mesh for the treatment of women with pelvic organ prolapse – Proceedings of the Obstetrics and Gynecology Devices Advisory Committee Meeting. September 2011, Gaithersburg, MD, USA.

Gee A, Chapman G, Paraiso MF. Where Are We Now? Urogynecologic Mesh and Present Recommendations. J Gynecol Surg. 2023; 39:30-35.

Deng T, Liao B, Luo D et al. Risk factors for mesh erosion after female pelvic floor reconstructive surgery: A systematic review and meta-analysis. BJU Int. 2016; 117:323-343.

Long CY, Lo TS, Wang CL et al. Risk factors of surgical failure following transvaginal mesh repair for the treatment of pelvic organ prolapse. Eur J Obstet Gynecol Reprod Biol. 2012; 161:224-227.

Gigliobianco G, Regueros SR, Osman NI et al. Biomaterials for pelvic floor reconstructive surgery: How can we do better? Biomed Res Int. 2015; 968087.

Miao L, Wang F, Wang L et al. Physical characteristics of medical textile prostheses designed for hernia repair: A comprehensive analysis of select commercial devices. Materials (Basel). 2015; 8:8148–8168.

Feola A, Barone W, Moalli P, Abramowitch S. Characterizing the ex vivo textile and structural properties of synthetic prolapse mesh products. Int Urogynecol J, 2013; 24:559-64.

Mancuso E, Downey C, Doxford-Hook E, et al. The use of polymeric meshes for pelvic organ prolapse: Current concepts, challenges, and future perspectives. J Biomed Mater Res B Appl Biomater. 2020; 108:771-789.

Feola AJ. Impact of vaginal synthetic prolapse meshes on the mechanics of the host tissue response. PhD dissertation, University of Pittsburg, USA, 2011.

Khatoon Z, McTiernan CD, Suuronen EJ et al. Bacterial biofilm formation on implantable devices and approaches to its treatment and prevention. Heliyon, 2018; 4:e01067.

Falagas ME, Velakoulis S, lavazzo C, Athanasiou S. Mesh-related infections after pelvic organ prolapse repair surgery. Eur J Obstet Gynecol Reprod Biol, 2007; 134:147-156.

Boulanger L, Boukerrou M, Rubod C et al. Bacteriological analysis of meshes removed for complications after surgical management of urinary incontinence or pelvic organ prolapse. Int Urogynecol J. 2008; 19:827-831.

Kaelin-Gambirasio I, Jacob S, Boulvain M et al. Complications associated with transobturator sling procedures: Analysis of 233 consecutive cases with a 27 months follow-up. BMC Women’s Health. 2009; 9:28.

Barone WR, Moalli PA, Abramowitch SD. Textile properties of synthetic prolapse mesh in response to uniaxial loading. Am J Obstet Gynecol. 2016; 215:326.e1-9.

Ugianskiene A, Davila GW, Su, TH. FIGO review of statements on use of synthetic mesh for pelvic organ prolapse and stress urinary incontinence. Int J Gynaecol Obstet. 2019; 147:147-155.

Chughtai B, Mao J, Buck J, et al. Use and risks of surgical mesh for pelvic organ prolapse surgery in women in New York state: Population based cohort study. BMJ. 2015; 350:h2685.

Ford AA, Rogerson L, Cody JD, et al. Mid-urethral sling operations for stress urinary incontinence in women. Cochrane Database Syst Rev. 2017 Jul 31;7(7):CD006375.

Cervigni M, Natale F. The use of synthetics in the treatment of pelvic organ prolapse. Curr Opin Urol. 2001; 11:429-435. Scholar Publishing

Milani AL, Withagen MIJ, Vierhout ME. Outcomes and predictors of failure of trocar-guided vaginal mesh surgery for pelvic organ prolapse. Am J Obstet Gynecol. 2012; 206:440.el-8.

Azadi A, Jasinski JB, Francis SL et al. Evaluation of surgical instrument handling on polypropylene mesh using scanning electron microscopy. Int Urogynecol J. 2014; 25:651-656.

Al-Kharabsheh AM, Lo TS, Cortes EFM, et al. Conventional surgery for recurrent pelvic organ prolapse with mesh erosion after failed transvaginal mesh operation. Gynecol Minim lnvasTher. 2015; 4:44-46.

Iakovlev V, Guelcher SA, Bendavid R. Degradation of polypropylene in vivo: A microscopic analysis of meshes explanted from patients. J Biomed Mater Res Part B. Appl Biomat. 2017; 105:237-248.

Iakovlev V, Carey ET, Steege J. Pathology of explanted transvaginal meshes. Intern J Med Health, Pharmac Biomed Eng. 2014; 8:549-552.

Clavé A, Yahi H, Hammou JC, et al. Polypropylene as a reinforcement in pelvic surgery is not inert: comparative analysis of 100 explants. Int Urogynecol J. 2010; 21:261-270.

Diedrich CM, Verhorstert KWJ, Riool M, et al. Transvaginal mesh-related complications and the potential role of bacterial colonization: An exploratory observational study. J Minim Invas Gynecol, 2023; 30:205-215.

Guzmán-Soto I, McTiernan C, Gonzalez-Gomez M et al. Mimicking biofilm formation and development: Recent progress in in vitro and in vivo biofilm models. iScience. 2021; 24:102443.

Su Y, Yrastorza JT, Matis M et al. Biofilms: formation, research models, potential targets, and methods for prevention and treatment. Adv Sci (Weinh). 2022;9:e2203291.

Crivello G, Fracchia L, Ciardelli G, et al. In vitro models of bacterial biofilms: Innovative tools to improve understanding and treatment of infections. Nanomaterials (Basel). 2023; 13:904.

Stokes K, McVenes R and Anderson JM. Polyurethane elastomer biostability. J Biomater Appl. 1995; 9:321-54.

Yang M, Zhang Z, Hahn C et al. Totally implantable artificial hearts and left ventricular assist devices: Selecting impermeable polycarbonate urethane to manufacture ventricles. J Biomed Mater Res. 1999; 48:13-23.

Urban E, King MW, Guidoin R, et al. Why make monofilament sutures out of polyvinylidene fluoride? ASAlO J, 1992; 40:145-156.

Mary C, Marois Y, King MW, et al. Comparison of the in vivo behavior of polyvinylidene fluoride and polypropylene sutures used in vascular surgery. ASAlO J, 1998; 44:199-206.

Ren J, Murray R, Wong, CS, et al. Development of 3D printed biodegradable mesh with antimicrobial properties for pelvic organ prolapse. Polymers (Basel). 2022; 14:763.

Seipelt RG, Vazquez-Jimenez JF, Seipelt IM, et al. The St. Jude "Silzone" valve: Midterm results in treatment of active endocarditis. Ann Thorac Surg. 2001; 72:758-762.

Noor I, Nasir MH, Rheman AU, et al. Medicinal and immunological aspects of bacteriophage therapy to combat antibiotic resistance. Explor Med. 2024; 5:215-231.

Fowoyo P. Phage therapy: Clinical applications, efficacy, and implementation hurdles. Open Microbiol J. 2024; 18:E18742858281566. Scholar Publishing FIGURES

Downloads

Published

2026-09-22

How to Cite

Rousseau, M., Li, C., Wei, K., Li, Y., Philippe, E., Sun, Y., … Guidoin, R. (2026). Histopathologic Analysis of Explanted Transvaginal Polypropylene Mesh. British Journal of Healthcare and Medical Research, 13(05), 55–74. https://doi.org/10.14738/bjhr.1305.12208

Most read articles by the same author(s)